Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study to Assess Efficacy and Safety of a New Compression System in the Management of Venous Leg Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inpatients or outpatients.~* Agreeing to wear a multilayer compression system throughout the study period.~* Presenting with an active venous leg ulcer: Duration between 1-24 months (whether a new ulcer or a recurrent ulcer); Surface area between 2-50 cm2; Venous, superficial or post-thrombotic ulcer confirmed by Doppler ultrasonography (dated within six months).~* With ankle circumference between 18-25 cm to allow the laying of the compression system.~* Able to follow the study instructions.~* Having read the information sheet and dated and signed the informed consent form.~* Covered by a health insurance system.~Exclusion Criteria:~* Scheduled surgery for the ulcer during the 16 weeks following inclusion.~* Clinical superinfected ulcer not controlled oral antibiotics.~* Malignant ulcer.~* Ulcer surface totally covered with dry fibrinous tissue or covered with black necrotic plaque on over 10% of its surface.~* Deep Vein Thrombosis within the last 3 months.~* Corticosteroids treatment (equivalent to more than 10 mg per day of prednisolone) ongoing or planned during the study.~* Radiotherapy, chemotherapy or immunosuppressive therapy ongoing or planned during the study.~* Erysipelas and lymphangitis.~* Lower extremity arterial disease or microangiopathy (Ankle Brachial Pressure Index \<0.8 or\> 1.3).~* Uncontrolled non-insulin dependent diabetes (HbA1c\> 8%).~* Insulin-dependent diabetes.~* Confined to bed.~* With any uncontrolled severe and progressive disease.~* With a known or suspected hypersensitivity to any of the components of the study devices.~* Who had participated in a previous clinical study within the past 3 months.~* Pregnant women.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- Kit Biflex (Type: EXPERIMENTAL): The Kit Biflex® will be applied according to manufacturer recommendations for 16 weeks or until full healing.
- Profore (Type: ACTIVE_COMPARATOR): The compression system Profore will be applied according to manufacturer recommendations for 16 weeks or until full healing.

Based on this trial design, predict the completion outcome and termination type (if applicable).